Blood Group (BG) Prevalence In End-Stage (ES) Renal Disease (RD): Relationship To Ristocetin Willebrand Factor (VIII: RWF) And Platelet Survival (PS) [PDF]
Victor J. Torres +5 more
openalex +1 more source
Asialo-von Willebrand factor inhibits platelet adherence to human arterial subendothelium: discrepancy between ristocetin cofactor activity and primary hemostatic function [PDF]
Jeanne B. Lawrence, HR Gralnick
openalex +1 more source
Inhibition of ristocetin-induced platelet agglutination by vancomycin [PDF]
JL Moake +4 more
openalex +1 more source
Corrigendum to 'Deep molecular modeling and mechanistic insights into type 2A von Willebrand disease with von Willebrand factor A2 domain mutations': [Research and Practice in Thrombosis and Haemostasis 9(7) (2025) 103233]. [PDF]
Seidizadeh O +7 more
europepmc +1 more source
Clinical and laboratory diagnosis of von Willebrand disease. [PDF]
Tosetto A, Eikenboom J.
europepmc +1 more source
Some factors affecting fibrinogen precipitation by ristocetin: ultrastructure of precipitates [PDF]
C.-H. Ts'Ao, D Green, EC Rossi
openalex +1 more source
Developing an artificial intelligence-generated peptide targeting platelet-type von Willebrand disease. [PDF]
Kazmirchuk TDD +12 more
europepmc +1 more source

